Severe Cerebral Salt Wasting in Autoimmune Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0886; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received corticosteroids and rituximab 1000 mg, with a second dose planned in two weeks followed by maintenance every six months. Hypovolemia, polyuria, negative fluid balance, severe natriuresis, hypokalemia, persistent uricosuria, and response to saline/fludrocortisone supported CSW. Treatment requires aggressive sodium and volume repletion rather than fluid restriction."
Cardiovascular • CNS Disorders • Heart Failure • Immunology • GFAP
|
|
Cristofer Francisco Santamaria Garcia; Ryan P. Flood
|